Redefining Left Ventricular Assist Device Indications and Strategies-Reply

Affiliations

¹ Center for Advanced Heart Disease, Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts.
² Montefiore Einstein Center for Heart and Vascular Care, New York, New York.

Comment

Mandeep R Mehra et al. JAMA Cardiol. 2021.

. 2021 Jan 1;6(1):120-121.

doi: 10.1001/jamacardio.2020.4323.

¹ Center for Advanced Heart Disease, Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts.
² Montefiore Einstein Center for Heart and Vascular Care, New York, New York.

No abstract available

Comment on

Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
Goldstein DJ, Naka Y, Horstmanshof D, Ravichandran AK, Schroder J, Ransom J, Itoh A, Uriel N, Cleveland JC Jr, Raval NY, Cogswell R, Suarez EE, Lowes BD, Kim G, Bonde P, Sheikh FH, Sood P, Farrar DJ, Mehra MR. Goldstein DJ, et al. JAMA Cardiol. 2020 Apr 1;5(4):411-419. doi: 10.1001/jamacardio.2019.5323. JAMA Cardiol. 2020. PMID: 31939996 Free PMC article. Clinical Trial.
Redefining Left Ventricular Assist Device Indications and Strategies.
Mehmood M. Mehmood M. JAMA Cardiol. 2021 Jan 1;6(1):119-120. doi: 10.1001/jamacardio.2020.4320. JAMA Cardiol. 2021. PMID: 32965462 No abstract available.
Redefining Left Ventricular Assist Device Indications and Strategies.
Pal N, Nelson M, Butterworth J. Pal N, et al. JAMA Cardiol. 2021 Jan 1;6(1):119. doi: 10.1001/jamacardio.2020.4303. JAMA Cardiol. 2021. PMID: 32965487 No abstract available.